Cheng, C.-F.; Yang, R.-B.; Chen, W.-T.; Chung, J.-F.; Ku, H.-C.
An ATF3 Inducer Ameliorates Metabolic Dysfunction-Associated Steatotic Liver Disease Through the AMPK and PKA Pathways. Int. J. Mol. Sci. 2025, 26, 11877.
https://doi.org/10.3390/ijms262411877
AMA Style
Cheng C-F, Yang R-B, Chen W-T, Chung J-F, Ku H-C.
An ATF3 Inducer Ameliorates Metabolic Dysfunction-Associated Steatotic Liver Disease Through the AMPK and PKA Pathways. International Journal of Molecular Sciences. 2025; 26(24):11877.
https://doi.org/10.3390/ijms262411877
Chicago/Turabian Style
Cheng, Ching-Feng, Ruey-Bing Yang, Wen-Ting Chen, Jia-Fang Chung, and Hui-Chen Ku.
2025. "An ATF3 Inducer Ameliorates Metabolic Dysfunction-Associated Steatotic Liver Disease Through the AMPK and PKA Pathways" International Journal of Molecular Sciences 26, no. 24: 11877.
https://doi.org/10.3390/ijms262411877
APA Style
Cheng, C.-F., Yang, R.-B., Chen, W.-T., Chung, J.-F., & Ku, H.-C.
(2025). An ATF3 Inducer Ameliorates Metabolic Dysfunction-Associated Steatotic Liver Disease Through the AMPK and PKA Pathways. International Journal of Molecular Sciences, 26(24), 11877.
https://doi.org/10.3390/ijms262411877